Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fluidigm Corp (NASDAQ:FLDM)

Delayed Data
As of 1:04pm ET
 -0.09 / -1.94%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Fluidigm Corp. develops, manufactures, and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 243-6628



Mutual fund holders51.07%
Other institutional50.63%
Individual stakeholders3.01%

Top Executives

Stephen Christopher LinthwaitePresident, CEO, Chief Operating Officer & Director
Vikram JogChief Financial Officer
Nicholas S. KhadderSecretary & Chief Compliance Officer
Jennifer Ling LeePrincipal Accounting Officer, VP & Controller
Ana PetrovicDirector-Corporate Development & IR